platinum-sensitive relapsed ovarian cancer: rucaparib
Published 6 years ago • 385 plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
5:18
rucaparib for ovarian cancer
-
5:56
approaching platinum-sensitive recurrent ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
11:05
parp inhibitors in recurrent ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
5:27
recurrent ovarian cancer; considerations beyond the platinum-free interval
-
8:03
bevacizumab in platinum-sensitive ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
2:31
should all platinum sensitive patients recieve parp inhibitors?